Healthcare News and Research

Latest Healthcare News and Research

Study: Hot flashes are not adequately managed in patients treated for breast cancer

Hot flushes are one of the most distressing conditions faced by women who have been treated for breast cancer, but they are not being adequately addressed by healthcare professionals and some women consider giving up their post cancer medication to try and stop them, a new study has shown.

6 Nov 2014

Weight-loss surgery minimizes use of medicines in people with obesity

Patients with obesity take significantly fewer medications after weight-loss surgery than their non-surgical counterparts, and end up spending 22.4 percent less on drugs for diabetes and heart disease after four years, according to new research.

6 Nov 2014

Researchers develop mouse model that reproduces most typical features of Noonan syndrome

Noonan syndrome is a rare disease that is characterised by a set of pathologies, including heart, facial and skeletal alterations, pulmonary stenosis, short stature, and a greater incidence of haematological problems (mainly juvenile myeloid leukaemia, or childhood leukaemia).

6 Nov 2014

APHON announces recipients of 2014 APHON Membership Awards

The Association of Pediatric Hematology/Oncology Nurses announced the recipients of the 2014 APHON Membership Awards at its 38th Annual Conference and Exhibit, held September 4-6 in Portland, OR. APHON Membership Awards recognize members who have shown outstanding achievement in their field.

6 Nov 2014

MMIS launches MediSpend Federal solution for life sciences industry

MMIS, creator of The MediSpend Global Compliance Platform, the leading global compliance and transparency solution for the life sciences industry, today announced a new solution, MediSpend Federal to support small to mid-size companies in the life sciences industry.

6 Nov 2014

Eight million US women skip cervical cancer screening in the past five years

Despite evidence that cervical cancer screening saves lives, about eight million women ages 21 to 65 years have not been screened for cervical cancer in the past five years, according to a new Vital Signs report from the Centers for Disease Control and Prevention. More than half of new cervical cancer cases occur among women who have never or rarely been screened.

6 Nov 2014

Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery

Insomnia is a "prevalent and persistent" problem for patients in the early phases of recovery from the disease of addiction—and may lead to an increased risk of relapse, according to a report in the November/December Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

6 Nov 2014

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy.

5 Nov 2014

Hospira launches Paricalcitol Injection

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar. Hospira obtained U.S. Food and Drug Administration approval of paricalcitol on Oct. 21 and launched the product Nov. 1.

5 Nov 2014

Gentiva Health Services reports revenues of $498.0 million for Q3 2014

Gentiva Health Services, Inc., one of the largest providers of home health, hospice and community care services in the United States, today reported net revenues of $498.0 million, adjusted EBITDA of $48.5 million and adjusted income attributable to Gentiva shareholders per diluted share of $0.28.

5 Nov 2014

Ranbaxy obtains FDA approval to manufacture, market Fenofibrate Capsules USP, 43 mg and 130 mg

Ranbaxy Laboratories Limited announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Fenofibrate Capsules USP, 43 mg and 130 mg. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Antara Capsules, 43 and 130 mg, respectively, of Lupin Atlantis.

5 Nov 2014

Modern bariatric surgery can cut medications in obesity patients

5 Nov 2014

BioElectronics to present innovative chronic pain therapy at OTC Pharma Asia Conference

BioElectronics Corporation, the maker of advanced consumer and healthcare medical devices announced today that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics' innovative chronic pain therapy at the OTC Pharma Asia Conference, on Tuesday, March 3, 2015 in Singapore.

5 Nov 2014

Abide, Oxford partner to explore therapeutic potential of serine hydrolases

Abide Therapeutics announced today that the Company has entered into a collaborative agreement with the University of Oxford and the Oxford University Hospitals NHS Trust to explore the therapeutic potential of serine hydrolases, one of the largest enzyme classes with validated but under explored class of drug targets.

5 Nov 2014

Use of preventive dental care rises among Medicaid-enrolled children in Pennsylvania

A study conducted by researchers at The Children's Hospital of Philadelphia's PolicyLab shows the proportion of US-born, Medicaid-enrolled children in Pennsylvania who utilized preventive dental care rose significantly for children ages 5-10 years from 2005-2010, with marked gains among Latino children.

4 Nov 2014

Cellular-level changes in nerve structure and function may contribute to migraine headaches

A new study shows cellular-level changes in nerve structure and function that may contribute to the development of migraine headaches, reports the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

4 Nov 2014

Study shows that 140 million American adults recommended for behavioral weight-loss treatment

New research shows that 140 million American adults - about 65 percent - are recommended for behavioral weight-loss treatment, with 83% of those (or 116 million) considered for pharmacotherapy.

4 Nov 2014

Major international health conference to be held next week in Singapore

The world is rapidly shrinking at the same time that medical collaborations are expanding - for the benefit of patient care right across the globe, a major international health conference in Singapore will hear next week.

4 Nov 2014

Resilience training program may help ICU nurses better handle stressful work environment

A multifaceted approach to teaching coping mechanisms may help critical care nurses better handle their stressful work environment, according to a study in the November issue of American Journal of Critical Care (AJCC).

4 Nov 2014

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.

4 Nov 2014

Healthcare News and Research

Latest Healthcare News and Research

Study: Hot flashes are not adequately managed in patients treated for breast cancer

Weight-loss surgery minimizes use of medicines in people with obesity

Researchers develop mouse model that reproduces most typical features of Noonan syndrome

APHON announces recipients of 2014 APHON Membership Awards

MMIS launches MediSpend Federal solution for life sciences industry

Eight million US women skip cervical cancer screening in the past five years

Effective treatment for sleep disturbance may lower risk of drug and alcohol relapse recovery

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Hospira launches Paricalcitol Injection

Gentiva Health Services reports revenues of $498.0 million for Q3 2014

Ranbaxy obtains FDA approval to manufacture, market Fenofibrate Capsules USP, 43 mg and 130 mg

Modern bariatric surgery can cut medications in obesity patients

BioElectronics to present innovative chronic pain therapy at OTC Pharma Asia Conference

Abide, Oxford partner to explore therapeutic potential of serine hydrolases

Use of preventive dental care rises among Medicaid-enrolled children in Pennsylvania

Cellular-level changes in nerve structure and function may contribute to migraine headaches

Study shows that 140 million American adults recommended for behavioral weight-loss treatment

Major international health conference to be held next week in Singapore

Resilience training program may help ICU nurses better handle stressful work environment

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in